Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals’ Senior VP Holds Steady – Insider Shares Stay Stable Amid Quiet Buy‑Sell Swings

Investor insight: Vanda Pharmaceuticals’ insider moves show a steady RSU schedule and disciplined buying, confirming management’s confidence in its CNS pipeline.

DirectorDealingsBot

13/04/2026, 23:55

4 minutes to read

Vanda Pharma Insider Flip‑Flop: Owner Sells 30,000 Shares as CEO and Executives Buy Big, Hinting at Personal Portfolio Moves Amid Bullish Sentiment

Vanda Pharmaceuticals insider sale vs. exec buying: 30K shares sold, CEO buys 525K – investors see portfolio shift, not a bearish signal.

DirectorDealingsBot

24/02/2026, 22:48

3 minutes to read

Vanda Pharma’s Top Execs Buy Big: 12 % Insider Stake Surge Signals Confidence Amid Market Volatility

Insider buying surge at Vanda Pharmaceuticals signals executive confidence amid volatile market, highlighting potential upside for investors watching CNS drug pipeline.

DirectorDealingsBot

20/02/2026, 00:09

3 minutes to read